Conveyance of sofosbuvir through vesicular lipid nanocarriers as an effective strategy for management of viral meningitis

BS Satapathy, PK Sahoo, S Pattnaik, AK Nayak… - RSC …, 2023 - pubs.rsc.org
This study aimed to deliver a potential water-soluble antiviral drug (sofosbuvir) through
optimized vesicular lipid nanocarriers (LNs) to the rat brain as a novel strategy against viral …

Nanostructured lipidic carriers of lopinavir for effective management of HIV-associated neurocognitive disorder

B Garg, S Beg, R Kumar, OP Katare, B Singh - Journal of Drug Delivery …, 2019 - Elsevier
The current research work entails the formulation, optimization and evaluation of nanolipidic
carriers of an antiretroviral drug, lopinavir for brain targeting to reduce HIV associated …

Indinavir-loaded nanostructured lipid carriers to brain drug delivery: optimization, characterization and neuropharmacokinetic evaluation

M Nasiri, A Azadi, MRS Zanjani… - Current Drug …, 2019 - ingentaconnect.com
Purpose: As an anti-retroviral Protease Inhibitor (PI), Indinavir (IDV) is part of the regimen
known as Highly Active Anti-Retroviral Therapy (HAART) widely used for Human …

Enhanced Delivery of Lopinavir to the Cns Using Compritol®-Based Solid Lipid Nanoparticles

A Alex, W Paul, AJ Chacko, CP Sharma - Therapeutic delivery, 2011 - Taylor & Francis
Background: Protease inhibitors such as lopinavir have negligible permeability to the CNS
due to blood–brain and blood–cerebrospinal fluid interfaces. An attempt has been made to …

Cationic solid lipid nanoparticles with cholesterol‐mediated surface layer for transporting saquinavir to the brain

YC Kuo, CC Wang - Biotechnology Progress, 2014 - Wiley Online Library
Cholesterol‐mediated cationic solid lipid nanoparticles (CSLNs) were formulated with
esterquat 1 (EQ 1) and stearylamine as positively charged external layers on hydrophobic …

Freeze-dried lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: statistical optimization, in vitro and in vivo evaluations

AA Khan, J Mudassir, S Akhtar, V Murugaiyah… - Pharmaceutics, 2019 - mdpi.com
Nanostructured lipid carriers (NLCs) loaded with lopinavir (LPV) were prepared by the high-
shear homogenization method. The LPV-NLCs formulations were freeze-dried using …

Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study

V Pokharkar, A Patil-Gadhe, P Palla - Biomedicine & pharmacotherapy, 2017 - Elsevier
Intranasal delivery is a potential platform that can be employed in targeting the antiretrovirals
(ARVs) to reach HIV that harbors in the central nervous system. The objective of the study …

[HTML][HTML] Nanostructured lipid carriers (NLCs)-based intranasal Drug Delivery System of Tenofovir disoproxil fumerate (TDF) for brain targeting

A Sarma, MK Das, T Chakraborty, S Das - Res. J. Pharm. Technol, 2020 - rjptonline.org
Brain is one of the dominant reservoirs of HIV. Blood Brain Barrier (BBB) provides a great
challenge in the delivery of Tenofovir disoproxil fumerate (TDF) to CNS after systemic …

Lipid Based Nanocarriers for Delivery of Anti-HIV Drugs: A Mini Review

D Mishra, AB Jindal - Nanoscience & Nanotechnology-Asia, 2018 - ingentaconnect.com
Introduction: At the end of 2014, almost 36.9 million people were living with HIV which has
put the HIV infection in the list of major public health issues. Although almost thirty drugs are …

Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects

S Maqsood, FU Din, SU Khan, E Elahi, Z Ali… - Life Sciences, 2022 - Elsevier
Aims Herein, we investigate the potential of levosulpiride-loaded nanostructured lipid
carriers (LEVO-NLCs) for effective brain delivery with anti-psychotic and antidepressant …